•  
  •  
  •  
  •  

2026-03-06 15:13:00

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • Ramky Infrastructure Wins ₹1,401.84 Crore Contract from Maharashtra Industrial Township Ltd for Dighi Port Industrial Area Project
  • Moneyboxx Finance Raises ₹33.4 Crore in Equity to Accelerate Growth and Strengthen Capital Base
  • Provigil Surveillance Ltd receives LOA for order worth Rs. 6.16 crore
  • Hannah Joseph Hospital receives award
  • Shree Refrigerations Ltd plans inauguration of new facility

Keywords Selected:  Approval

IPO News

  • VMS TMT Limited Gets SEBI Nod to Float an IPO
  • Rachit Prints Limited receives in-principle approval from BSE SME Exchange, Plans to Raise ₹19.50 Crore
  • Icon Facilitators Announces BSE SME IPO Approval, Targets ₹22 Crore Fundraise
  • Crizac Limited gets Sebi Nod for Rs 1,000 cr IPO
  • Jungle Camps India Limited plans to raise around Rs. 30 crores from IPO
  • Senores Pharmaceuticals gets Sebi nod for IPO
  • Telangana-based Standard Glass Lining Technology Limited gets Sebi nod for IPO
  • IT Solutions provider Orient Technologies gets Sebi nod for IPO
  • Gala Precision Engineering gets Sebi nod for IPO
  • Noida-based Interarch Building Products Limited gets SEBI nod for IPO
  • Nephro Care India Limited plans to raise Rs. 35-40 crore from its upcoming IPO
  • Allied Blenders and Distillers Limited gets Sebi nod for Rs 1500 crore IPO
  • Sanstar Limited, gets SEBI nod to float IPO
  • Asirvad Micro Finance Limited gets Sebi nod for IPO
  • Kronox Lab Sciences gets SEBI nod to float IPO
  • Fairfax-backed Go Digit General Insurance gets Sebi nod for IPO
  • Gopal Snacks Limited gets Sebi nod for Rs 650 crore IPO
  • Juniper Hotels gets Sebi nod for its Rs 1,800 crore IPO
  • Stanley Lifestyles gets Sebi nod for IPO
  • Onest and Shiva Pharmachem gets Sebi nod for IPO
  • Mukka Proteins Limited gets Sebi Nod for IPO
  • Ludhiana-based Auto Component Maker Happy Forgings Limited receives Sebi nod to float its IPO
  • Cello World Limited gets Sebi nod for its Rs 1750 crore IPO
  • ESAF Small Finance Bank gets Sebi nod for IPO

Stock Report

  • Gland Pharma Ltd receives tentative approval from USFDA
  • Glenmark Specialty SA Receives U.S. FDA Approval for Fluticasone Propionate Inhalation Aerosol USP, 44 mcg per actuation, with 180-Day Competitive Generic Therapy Exclusivity
  • MAS Financial Services Secures RBI Nod for Factoring Business Expansion
  • Caplin Steriles gets USFDA approval for Desmopressin Acetate Injection
  • Zydus receives final approvals from USFDA for Ivermectin Tablets USP, 3 mg and Dapsone Tablets USP, 25 mg and 100 mg
  • Eugia Pharma receives USFDA Approval for Everolimus Tablets
  • Alembic Pharmaceuticals Limited announces USFDA Final Approval for Lamotrigine Orally Disintegrating Tablets USP, 25 mg, 50 mg, 100 mg and 200 mg
  • Biocon obtains approval for weight management drug, Liraglutide, in the United States
  • Lupin announces the approval and launch of Brivaracetam Oral Solution in the United States
  • Alembic Pharmaceuticals Limited announces USFDA Final Approval for Efinaconazole Topical Solution, 10%
  • Caplin Steriles gets USFDA approval for Sodium Phosphates Injection
  • Indoco Remedies receives final ANDA approval from USFDA for Brivaracetam Oral Solution, 10 mg/mL
  • MobiKwik gets BSE approval to commence Stock Broking business
  • Lupin receives European Commission approval for Biosimilar Ranibizumab
  • NHPC approves investment proposals in Hydro Electric Projects
  • Zydus receives final approval from USFDA for Bosentan tablets for oral suspension, 32 mg
  • RBI grants approval for Bain Capital to acquire joint control in Manappuram Finance
  • OneSource-Hikma partnership secures approval to commercialise generic version of Ozempic® in Saudi Arabia
  • Alembic Pharmaceuticals gets USFDA nod for generic Parkinson's disease treatment tablets
  • Zydus receives tentative approval from USFDA for Dapagliflozin Tablets, 5 mg and 10 mg
  • NATCO receives Tentative Approval for Erdafitinib Tablets from USFDA
  • SPARC announces receipt of Priority Review Voucher associated with Sezaby® Approval
  • Epic Renewable Projects Pvt Ltd receives approvals for 2.70 MWh Solar Power Project
  • Pine Labs Ltd receives RBI nod for acquisition of 100% stake in Agya Technologies

Industry News

  • ASK Asset & Wealth Management Group receives SEBI nod to launch its Mutual Fund business
  • Ashika Investment Managers Launches SmartAlpha Fund, a New Open-Ended Category III Data Strategy Fund
  • RBI grants NBFC license to Equirus Group
  • NCLT approves slice and North East Small Finance Bank's Merger
  • NSE launches WTI Crude Oil and Natural Gas futures contracts
  • Zero To One, an angel network, gets SEBI nod to launch INR 300cr Alternative Investment Fund
  • Pre Construction Tips: Things to Check
  • NTT DATA Payment Services accorded approval by RBI for payment aggregator license
  • Insurance product approvals made easy - Steps towards ease of doing business

Latest Post

  • Ramky Infrastructure Wins ₹1,401.84 Crore Contract from Maharashtra Industrial Township Ltd for Dighi Port Industrial Area Project
  • Moneyboxx Finance Raises ₹33.4 Crore in Equity to Accelerate Growth and Strengthen Capital Base
  • Provigil Surveillance Ltd receives LOA for order worth Rs. 6.16 crore
  • Hannah Joseph Hospital receives award
  • Shree Refrigerations Ltd plans inauguration of new facility


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2025